Drug General Information
Drug ID
D0Q3PD
Former ID
DCL001234
Drug Name
S-297995
Drug Type
Small molecular drug
Indication Opioid induced adverse effect [ICD9: 304; ICD10:F11] Phase 2 [551683]
Company
Shionogi
Formula
C32H34N4O6
Canonical SMILES
CC(C)(C1=NC(=NO1)C2=CC=CC=C2)NC(=O)C3=C(C4C56CCN(C(C5(C<br />3)O)CC7=C6C(=C(C=C7)O)O4)CC8CC8)O
InChI
1S/C32H34N4O6/c1-30(2,29-33-27(35-42-29)18-6-4-3-5-7-18)34-28(39)20-15-32(40)22-14-19-10-11-21(37)25-23(19)31(32,26(41-25)24(20)38)12-13-36(22)16-17-8-9-17/h3-7,10-11,17,22,26,37-38,40H,8-9,12-16H2,1-2H3,(H,34,39)/t22-,26+,31+,32-/m1/s1
InChIKey
AXQACEQYCPKDMV-RZAWKFBISA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Opioid receptor Target Info Antagonist [551683]
References
Ref 551683Clinical pipeline report, company report or official report of Shionogi (2011).
Ref 551683Clinical pipeline report, company report or official report of Shionogi (2011).